Anand Bidarkar appointed vice-president of BD for Ecron Acunova
This article was originally published in Scrip
Dr Anand Bidarkar has been hired as vice-president of business development for the Ecron Acunova group. He has extensive functional experience in operations, business development, strategic partnerships and leading business units with multibillion dollar groups like Novartis, inVentiv and Apollo as well as with mid-sized firms like Sun Pharmaceuticals. Prior to joining EA, Dr Bidarkar was working with SIRO Clinpharm as vice-president of business development. He spearheaded alliance formation with complimentary service providers and transformed the business model of the company from being dependent on single project, single country contracts to programme level and multinational deals.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"